LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Molecular Templates and Millions of Other Companies

Sign up for full access to Molecular Templates information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Collaboration Potential Molecular Templates has a collaboration agreement with Bristol Myers Squibb for the discovery and development of novel products. This partnership opens opportunities for collaborative sales efforts and exploring synergies between the product portfolios of the two companies.

Expansion into Other Targets Molecular Templates is developing a pipeline of ETBs for targets such as CTLA-4, TIGIT, TROP2, and BCMA. By expanding into new targets, there is a potential for increased sales opportunities in targeting a broader spectrum of diseases and medical conditions.

Recent Acquisition BB Biotech AG recently acquired Molecular Templates. This acquisition can lead to new sales channels and expanded market reach as part of a larger organization, presenting potential cross-selling and up-selling opportunities.

Updates in Leadership Molecular Templates appointed new key personnel like Maurizio Voi as Chief Medical Officer. Leveraging the expertise of new leaders can enhance sales strategies, drive innovation, and potentially attract new business opportunities.

Strategic Reprioritization Following a 100-employee headcount reduction due to strategic reprioritization, there is a chance for sales professionals to reassess the sales approach and cater to the company's evolving focus, potentially identifying new areas of growth.

Similar companies to Molecular Templates

✕

Access Insights for Molecular Templates and Millions of Other Companies

Sign up for full access to Molecular Templates information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Molecular Templates Tech Stack

Molecular Templates uses 8 technology products and services including SiteCatalyst, Cloudflare, MySQL, and more. Explore Molecular Templates's tech stack below.

  • SiteCatalyst
    Analytics
  • Cloudflare
    Content Management System
  • MySQL
    Database
  • Underscore.js
    Javascript Libraries
  • Google Maps
    Maps
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • MediaElement.js
    Video Players

Media & News

Molecular Templates's Email Address Formats

Molecular Templates uses at least 2 format(s):
Molecular Templates Email FormatsExamplePercentage
First.Last@mtem.comJohn.Doe@mtem.com
91%
Last@mtem.comDoe@mtem.com
7%
First_Last@mtem.comJohn_Doe@mtem.com
1%
LastFirst@mtem.comDoeJohn@mtem.com
1%
First.Last@moleculartemplates.comJohn.Doe@moleculartemplates.com
93%
Last@moleculartemplates.comDoe@moleculartemplates.com
7%

Frequently Asked Questions

Where is Molecular Templates's headquarters located?

Minus sign iconPlus sign iconMolecular Templates's main headquarters is located at 9301 Amberglen Blvd Suite 100 Austin, Texas 78729 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Molecular Templates's phone number?

Minus sign iconPlus sign icon You can contact Molecular Templates's main corporate office by phone at
✕

Access Insights for Molecular Templates and Millions of Other Companies

Sign up for full access to Molecular Templates information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-512-930-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Molecular Templates's stock symbol?

Minus sign iconPlus sign iconMolecular Templates is a publicly traded company; the company's stock symbol is MTEM.

What is Molecular Templates's official website and social media links?

Minus sign iconPlus sign iconMolecular Templates's official website is mtem.com and has social profiles on LinkedIn.

How much revenue does Molecular Templates generate?

Minus sign iconPlus sign icon As of September 2024, Molecular Templates's annual revenue reached $7.5M.

What is Molecular Templates's SIC code NAICS code?

Minus sign iconPlus sign iconMolecular Templates's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Molecular Templates have currently?

Minus sign iconPlus sign iconAs of September 2024, Molecular Templates has approximately 72 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Operating Officer: K. Q.Chief Medical Officer At Molecular Templates: M. V.President & Cfo: J. K.. Explore Molecular Templates's employee directory with LeadIQ.

What industry does Molecular Templates belong to?

Minus sign iconPlus sign iconMolecular Templates operates in the Biotechnology Research industry.

What technology does Molecular Templates use?

Minus sign iconPlus sign iconMolecular Templates's tech stack includes SiteCatalystCloudflareMySQLUnderscore.jsGoogle MapsRSSOpen GraphMediaElement.js.

What is Molecular Templates's email format?

Minus sign iconPlus sign iconMolecular Templates's email format typically follows the pattern of . Find more Molecular Templates email formats with LeadIQ.

How much funding has Molecular Templates raised to date?

Minus sign iconPlus sign icon As of September 2024, Molecular Templates has raised $9.5M in funding. The last funding round occurred on Mar 28, 2024 for $9.5M.

When was Molecular Templates founded?

Minus sign iconPlus sign iconMolecular Templates was founded in 2001.
Molecular Templates

Molecular Templates

Biotechnology ResearchTexas, United States51-200 Employees

Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. MTEM’s pipeline of ETBs in development for other targets include CTLA-4, TIGIT, TROP2, and BCMA. MTEM has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

✕

Access Insights for Molecular Templates and Millions of Other Companies

Sign up for full access to Molecular Templates information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
9301 Amberglen Blvd Suite 100 Austin, Texas 78729 US
Phone number
✕

Access Insights for Molecular Templates and Millions of Other Companies

Sign up for full access to Molecular Templates information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-512-930-****
Website
mtem.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MTEM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $9.5M

    Molecular Templates has raised a total of $9.5M of funding over 17 rounds. Their latest funding round was raised on Mar 28, 2024 in the amount of $9.5M.

  • $10M

    Molecular Templates's revenue is in the range of $10M

Section iconFunding & Financials

  • $9.5M

    Molecular Templates has raised a total of $9.5M of funding over 17 rounds. Their latest funding round was raised on Mar 28, 2024 in the amount of $9.5M.

  • $10M

    Molecular Templates's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Molecular Templates and Millions of Other Companies

Sign up for full access to Molecular Templates information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.